1515 — China Resources Medical Holdings Balance Sheet
0.000.00%
- HK$4.25bn
- HK$6.01bn
- CNY9.85bn
- 50
- 95
- 30
- 64
Annual balance sheet for China Resources Medical Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | Interim Report | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 2,972 | 2,635 | 3,424 | 1,236 | 977 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 930 | 963 | 2,725 | 1,676 | 1,642 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,147 | 3,925 | 6,766 | 3,429 | 3,239 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,046 | 2,118 | 5,418 | 5,362 | 5,272 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 8,963 | 10,468 | 17,818 | 13,654 | 13,318 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,207 | 3,444 | 5,124 | 5,207 | 4,499 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2,858 | 4,017 | 8,308 | 7,842 | 7,105 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 6,105 | 6,451 | 9,509 | 5,812 | 6,214 |
| Total Liabilities & Shareholders' Equity | 8,963 | 10,468 | 17,818 | 13,654 | 13,318 |
| Total Common Shares Outstanding |